| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/14/2005 | WO2005033127A1 Method for the synthesis of n-[(s)-1-carbethoxybutyl]-(s)-alanine and use thereof for the synthesis of perindopril |
| 04/14/2005 | WO2004070054A3 Methods for preventing mitochondrial permeability transition |
| 04/14/2005 | US20050080133 Methods of inhibiting osteoclast activity |
| 04/14/2005 | US20050080017 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 04/14/2005 | US20050080016 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
| 04/14/2005 | US20050080005 Macrocyclic peptides active against the hepatitis C virus |
| 04/14/2005 | US20050079560 Detection and treatment of cancers of the colon |
| 04/14/2005 | DE10344848A1 New amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives useful to treat cardiovascular disorders or diseases; hypertension; sexual dysfunction; or neurodegenerative disorders |
| 04/14/2005 | DE10342108A1 Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung Basic-substituted Benzylaminanaloga as inhibitors of coagulation factor Xa, their preparation and use |
| 04/14/2005 | CA2540646A1 Antibacterial amide macrocycles |
| 04/14/2005 | CA2526425A1 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/13/2005 | EP1521769A2 Tubulysin conjugates |
| 04/13/2005 | EP1073453B1 Use of angiotensin analogs for the manufacture of a medicament for increasing white blood cell survival and mobilizing haematopoietic progenitor cells following chemotherapy |
| 04/13/2005 | EP0774971B1 Synthetic peptide inhibitors of hiv transmission |
| 04/13/2005 | CN1606564A Modular peptide-based reagent |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1196683C Amino-compound |
| 04/12/2005 | US6878804 Coupling a solid support derived from polystyrene crosslinked with divinylbenzene which is functionalized by 2-chlrotrityl linker with an N-protected derivatives of preferential amino acid |
| 04/12/2005 | US6878722 Substituted cycloalkyl P1′ hepatitis C virus inhibitors |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/07/2005 | WO2005030804A2 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 04/07/2005 | WO2005030796A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/07/2005 | WO2005030795A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compounds |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030135A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | US20050075293 Antidiabetic agents; anticholesterol agents; obesity; antiinflammatory agents; autoimmune disease; multiple sclerosis; antiarthritic agents |
| 04/07/2005 | US20050075281 Acylated nonadepsipeptides |
| 04/07/2005 | US20050075280 Novel antiarrythmic peptides |
| 04/07/2005 | US20050075279 Macrocyclic peptides active against the hepatitis C virus |
| 04/07/2005 | US20050074411 Synthesis of an magnetic resonance imaging (MRI) agent by reacting a peptide with p-xylylenediamine and covalently attaching a linker moiety, reacting with a precursor chelate moiety having protected carboxy groups, deprotecting, and chelating with a paramagnetic metal ion |
| 04/07/2005 | CA2540644A1 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 04/07/2005 | CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/07/2005 | CA2539973A1 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | CA2539895A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compo |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539486A1 Methods for preparing oil bodies comprising active ingredients |
| 04/06/2005 | EP1520858A1 Process for producing sugar peptide having asparagine sugar chain and the sugar peptide |
| 04/06/2005 | EP1520582A2 Use of dipeptidylpetidase inhibitors to regulate glucose metabolism |
| 04/06/2005 | EP1519946A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195773C Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/05/2005 | US6875874 Using thionyl chloride |
| 04/05/2005 | US6875743 Antiinflammatory agents; autoimmune disease |
| 04/05/2005 | US6875737 Multivalent compounds for crosslinking receptors and uses thereof |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | CA2235138C Reverse-turn mimetics and methods relating thereto |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028502A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/31/2005 | WO2005028501A1 Macrocyclic peptides active against the hepatitis c virus |
| 03/31/2005 | WO2005016283A3 Peptides for enhanced cell attachment and growth |
| 03/31/2005 | WO2005005461A3 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 03/31/2005 | WO2004101604A3 SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING 3,3-DIMETHYLBUTYRALDEHYDE PRECURSORS |
| 03/31/2005 | WO2004096212A9 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer |
| 03/31/2005 | WO2004075839A3 Methods and compositions for modulating apoptosis |
| 03/31/2005 | WO2003072754A3 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070505 Phosphinic pseudo-peptide derivatives for the selective inhibition of the active c-terminal site of angiotensin converting enzyme (I) (ace) |
| 03/31/2005 | US20050070480 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/31/2005 | US20050070479 Oligo or polyalkylene glycol-coupled thrombin inhibitors |
| 03/31/2005 | CA2538791A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/30/2005 | EP1517997A2 Luminogenic protease substrates |
| 03/30/2005 | EP1517915A2 Prodrugs of excitatory amino acids |
| 03/30/2005 | EP1026988A4 Novel fluorescent reporter molecules and their applications including assays for caspases |
| 03/30/2005 | EP0838474B1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient |
| 03/29/2005 | US6872805 Hepatitis C virus inhibitors |
| 03/29/2005 | US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 03/29/2005 | US6872520 Peptide for use in the detection of viral infection and diseases |
| 03/24/2005 | WO2005026733A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | WO2005026198A1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 03/24/2005 | WO2005012333A3 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 03/24/2005 | WO2005012328A3 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 03/24/2005 | WO2003045973A8 Peptides with growth inhibitory action |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065090 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin |
| 03/24/2005 | US20050065086 Adjust drug releasing characteristics, bioavailability of oral drug |
| 03/24/2005 | US20050065073 Aza-peptide macrocyclic hepatitis C serine protease inhibitors |
| 03/24/2005 | CA2538075A1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/23/2005 | EP1515984A1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/23/2005 | EP1515983A1 Antibacterial amide macrocycles |
| 03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
| 03/23/2005 | CN1599753A Gene regulatory peptides |
| 03/23/2005 | CN1599749A Peptides promoting cell adherence, growth and secretion |
| 03/23/2005 | CN1599748A Novel peptides and medicinal uses thereof |
| 03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/23/2005 | CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 03/23/2005 | CN1599577A Peptide-based multimeric targeted contrast agents |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1194007C Separation, synthesis and application in medicine for P6A'S metabolic product |
| 03/23/2005 | CN1194006C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 03/22/2005 | US6870028 Biologically active peptides and compositions, their use |
| 03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |
| 03/17/2005 | WO2005023857A2 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 03/17/2005 | WO2005023844A1 Compound modified with glycerol derivative |
| 03/17/2005 | WO2005023843A1 Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 03/17/2005 | WO2005023842A1 Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |